Ambry Dec 18, 2019 Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing Premium Oct 4, 2019 Adding RNA-Seq, Ambry Genetics Expects to Reduce VUS Results in Hereditary Cancer Tests Premium Sep 5, 2019 Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations Premium Jun 4, 2019 Color Panel Reveals Hereditary Cancer Risk in Trinidad and Tobago Breast Cancer Patients Premium Jan 22, 2019 Labs, Advocacy Groups Push Back on Medicare Policy Shift on NGS Testing for Hereditary Cancer Risk Premium Jun 6, 2017 Hereditary Cancer Panel Study Suggests Germline Mutations Missed in Some Pancreatic Cancers Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
